Nakaseomyces glabrata endocarditis: A therapeutic dilemma

Kin Ki Jim*, Joelle J. N. Daems, S. Matthijs Boekholdt, Karin van Dijk

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Candida infective endocarditis is a rare but serious entity that often requires aggressive treatment. However, treatment can be challenging in patients infected with drug-resistant fungi and/or with substantial comorbidity. Moreover, recommendations in treatment guidelines for these patients are based on limited clinical data due to their rarity. Here we report a case of Nakaseomyces glabrata (Candida glabrata) prosthetic valve endocarditis in a patient with congenital heart disease. This case illustrates a therapeutic dilemma for Nakaseomyces glabrata prosthetic valve endocarditis and the need for novel antifungal drugs and further clinical studies.
Original languageEnglish
Pages (from-to)54-57
Number of pages4
JournalMedical Mycology Case Reports
Publication statusPublished - 1 Jun 2023

Cite this